Targeted treatments have emerged as a safer and more effective option for eczema patients, but high costs remain a barrier.

A clinical review breaks down the latest best practices for managing severe atopic dermatitis (AD) in pregnancy. The review, which appears in Clinical Medicine, was developed by a team of British ...

Eczema, also known as atopic dermatitis, is a chronic inflammatory skin condition that affects millions of children and adults. It often causes itching, redness, dryness, flaking, and sometimes ...

Delgocitinib is the first FDA-approved topical JAK inhibitor for moderate to severe chronic hand eczema in adults. The DELTA 1 and DELTA 2 studies showed significant efficacy, with improved patient ...

Bambusa Therapeutics, Inc. (Bambusa Therapeutics), a clinical-stage biotechnology company advancing next-generation bispecific antibodies for immunology and inflammation, today announced the ...

Treatment options for severe chronic hand eczema are limited and carry troublesome adverse effects. Delgocitinib cream had superior efficacy compared with oral alitretinoin for this patient population ...

Living with eczema affects more than just the skin – it influences everything from sleep patterns to clothing choices and social interactions. This inflammatory skin condition, which comes from a ...

Everyday Health independently vets all recommended products. If you purchase a featured product, we may be compensated. Learn why you can trust us. Everyday Health independently vets all recommended ...

While babies’ skin is typically considered to be smooth, hydrated and, well, baby-soft, this isn’t always the case. In fact, at least one in five children has eczema (a condition that causes the skin ...